ResearcherUniversity Hospital Schleswig-HolsteinNo recent work listed

Freya A. Goumas

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5038112010. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper

Papers 2

Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer. Co-author DOI 10.1002/ijc.29445 ↗
Interleukin-6: a villain in the drama of pancreatic cancer development and progression. First author DOI 10.1016/s1499-3872(14)60259-9 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Reinhild Holmer · 2 shared papers, 2014–2015 · strength 0.10
- Paper Interleukin-6: a villain in the drama of pancreatic cancer development and progression. DOI 10.1016/s1499-3872(14)60259-9 ↗
- Paper Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models… DOI 10.1002/ijc.29445 ↗
Holger Kalthoff · 2 shared papers, 2014–2015 · strength 0.10
- Paper Interleukin-6: a villain in the drama of pancreatic cancer development and progression. DOI 10.1016/s1499-3872(14)60259-9 ↗
- Paper Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models… DOI 10.1002/ijc.29445 ↗
Karen Legler · 1 shared paper, 2015 · strength 0.04
- Paper Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models… DOI 10.1002/ijc.29445 ↗
Ulf Martin Geisen · 1 shared paper, 2015 · strength 0.04
- Paper Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models… DOI 10.1002/ijc.29445 ↗
Christoph Röcken · 1 shared paper, 2015 · strength 0.04
- Paper Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models… DOI 10.1002/ijc.29445 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.